Go to content
UR Home

Bristol-Myers Squibb (BMS) Immune Oncology Foundation (Award FA19-009)

Up a level
Export as
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Creators | Item type | No Grouping
Jump to: G | S
Number of items: 3.

G

Glehr, Gunther , Riquelme, Paloma, Yang Zhou, Jordi, Cordero, Laura, Schilling, Hannah-Lou, Kapinsky, Michael, Schlitt, Hans J., Geissler, Edward K., Burkhardt, Ralph , Schmidt, Barbara, Haferkamp, Sebastian, Hutchinson, James A. and Kronenberg, Katharina (2022) External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition. Frontiers in Immunology 13, p. 1011040.

S

Schilling, Hannah‐Lou, Hutchinson, James A. and Haferkamp, Sebastian (2022) Prediction of immune checkpoint blockade‐related hepatitis in metastatic melanoma patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20 (6), pp. 773-775.

Schilling, Hannah-Lou, Glehr, Gunther , Kapinsky, Michael, Ahrens, Norbert , Riquelme, Paloma , Cordero, Laura, Bitterer, Florian, Schlitt, Hans J. , Geissler, Edward K. , Haferkamp, Sebastian, Hutchinson, James A. and Kronenberg, Katharina (2021) Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications. Frontiers in Immunology 2021 (12), pp. 1-12. Fulltext restricted.

This list was generated on Sun May 19 22:36:53 2024 CEST.
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons